NCT01816815View on ClinicalTrials.gov

Study in Healthy Tubal Ligated Women to Evaluate Pharmacodynamics, Safety and Pharmacokinetics of BAY1002670

PHASE1CompletedINTERVENTIONAL
Enrollment

73

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

January 31, 2013

Conditions
Leiomyoma
Interventions
DRUG

BAY1002670

DRUG

Placebo

Trial Locations (6)

2060

Antwerp

10117

Berlin

13353

Berlin

41450

Neuss

89231

Neu-Ulm

BT2 7BA

Belfast

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY